Suppr超能文献

贫困人群中糖尿病代谢控制与药物依从性之间的关联。

The association between diabetes metabolic control and drug adherence in an indigent population.

作者信息

Schectman Joel M, Nadkarni Mohan M, Voss John D

机构信息

Department of Medicine, University of Virginia, Charlottesville, Virginia 22908, USA.

出版信息

Diabetes Care. 2002 Jun;25(6):1015-21. doi: 10.2337/diacare.25.6.1015.

Abstract

OBJECTIVE

Studies of the association between diabetes metabolic control and adherence to drug therapy have yielded conflicting results. Because low socioeconomic and minority populations have poorer diabetes outcomes and greater barriers to adherence, we examined the relationship between adherence and diabetes metabolic control in a large indigent population.

RESEARCH DESIGN AND METHODS

The study population consisted of patients receiving medical care from a university-based internal medicine clinic serving a low-income population in rural central Virginia. The sample comprised 810 patients with type 2 diabetes who received oral diabetes medications from the clinic pharmacy and had at least one HbA(1c) determination during the study period. Multiple linear regression was used to examine the association of HbA(1c) level as well as change in HbA(1c) level with medication adherence, demographic, and clinical characteristics.

RESULTS

Better metabolic control was independently associated with greater medication adherence, increasing age, white (versus African-American) race, and lower intensity of drug therapy. For each 10% increment in drug adherence, HbA(1c) decreased by 0.16% (P < 0.0001). Controlling for other demographic and clinical variables, the mean HbA(1c) of African-Americans was 0.29% higher than that of whites (P = 0.04). Additionally, the intensity of diabetes drug therapy for African-Americans was lower, as was their measured adherence to it. There was no association between metabolic control and gender, income, encounter frequency, frequency of HbA(1c) testing, or continuity of care.

CONCLUSIONS

Adherence to medication regimens for type 2 diabetes is strongly associated with metabolic control in an indigent population; African-Americans have lower adherence and worse metabolic control. Greater efforts are clearly needed to facilitate diabetes self-management behaviors of low-income populations and foster culturally sensitive and appropriate care for minority groups.

摘要

目的

关于糖尿病代谢控制与药物治疗依从性之间关联的研究结果相互矛盾。由于社会经济地位较低的人群和少数族裔人群的糖尿病治疗效果较差且依从性障碍更大,我们在一个大型贫困人群中研究了依从性与糖尿病代谢控制之间的关系。

研究设计与方法

研究人群包括从弗吉尼亚州中部农村地区一个为低收入人群服务的大学内科诊所接受医疗服务的患者。样本包括810例2型糖尿病患者,这些患者从诊所药房接受口服降糖药物治疗,且在研究期间至少进行过一次糖化血红蛋白(HbA1c)测定。采用多元线性回归分析糖化血红蛋白水平以及糖化血红蛋白水平变化与药物依从性、人口统计学和临床特征之间的关联。

结果

更好的代谢控制与更高的药物依从性、年龄增长、白人(与非裔美国人相比)种族以及较低的药物治疗强度独立相关。药物依从性每增加10%,糖化血红蛋白降低0.16%(P<0.0001)。在控制其他人口统计学和临床变量后,非裔美国人的平均糖化血红蛋白比白人高0.29%(P = 0.04)。此外,非裔美国人的糖尿病药物治疗强度较低,其测量的依从性也较低。代谢控制与性别、收入、就诊频率、糖化血红蛋白检测频率或医疗连续性之间无关联。

结论

在贫困人群中,2型糖尿病药物治疗方案的依从性与代谢控制密切相关;非裔美国人的依从性较低且代谢控制较差。显然需要做出更大努力来促进低收入人群的糖尿病自我管理行为,并为少数族裔群体提供具有文化敏感性和适当的医疗服务。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验